Levomepromazine - Schizophrenia

You are here : Home > Formulary Search > Levomepromazine - Schizophrenia

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

See narrative

Formulations :

Tablets

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Associated Icons :

NFD2

SPC

Restrictions / Comments :

Important

This drug (for this indication) has not been assessed for inclusion on the formulary. Contact your pharmacy team for advice on making an application to APC.

Documentation

No records returned.

PAD Profile

ChemicalSubstance :

Levomepromazine

Indication :

Schizophrenia

Group Name :

Keywords :

Brand Names Include :

Levorol

Important Information :

Latest Additions Date From :

Latest Additions Date To :

Guidelines :

Supporting Documents :

Other Indications

Below are listed other indications that Levomepromazine is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Schizophrenia.

No records returned.

Committee Recommendations (1)

25 Jun 24 - Not Set

Levomepromazine tablets 6.25mg

This drug has not yet been assessed for formulary status [for this indication] and is not currently on the APC work-plan.

This drug has not yet been evaluated by the Surrey Heartlands ICS Area Prescribing Committee (APC). As such, advice regarding safety, effectiveness (including cost-effectiveness) and its place in therapy is yet to be determined.

Before prescribing this drug/device it is recommended that clinicians contact their Medicines Optimisation team to discuss possible alternatives/options.

The APC will consider recommending the prescribing of this treatment upon submission of a formal request with its associated evidence. Clinicians can contact syheartlandsicb.APC@nhs.net if they wish to make a submission.